OCT Europe (Outsourcing in Clinical Trials) 2024
Join us at OCT Europe, happening May 7-8!
You can stop by booth #47 to meet TFS’s experienced CRO team and explore our specialized clinical development and resourcing solutions designed to elevate your clinical research. We combine the full-service capabilities and global reach of a large CRO with the flexibility and personal approach only a mid-size CRO can deliver.
Why TFS?
Experience scientific and medical excellence across diverse therapeutic areas. Our seasoned professionals ensure solution-driven outcomes, allowing sponsors to concentrate on advancing clinical innovations. TFS CRO provides industry-leading capabilities in the following areas:
- Oncology & Hematology
- Dermatology, Immunology, & Inflammatory Disease
- Ophthalmology
- Internal Medicine & Neuroscience
- Strategic Resourcing Solutions
Contact us today to connect during the conference and discover how TFS can be your strategic CRO partner in clinical development. See you at OCT Europe (Outsourcing in Clinical Trials) 2024!
Attend Our Presentation
- May 7th at 12:30pm
Patient Centricity Track - Pioneering Gene Therapy in Rare Diseases: A Path to Revolutionary Treatments
by Lakshmi Guduri
In this session, you can expect to:
- Gain insights into the transformative impact of gene therapy on rare disease treatment, underscoring a new era of medical breakthroughs.
- Learn about the complexities involved in conducting gene therapy trials, from the unique challenges to the innovative solutions.
- Understand TFS HealthScience’s approach to navigating the project management hurdles specific to gene therapy research.
About Our Presenter: Lakshmi Guduri
Lakshmi is a seasoned professional with an impressive 16-year tenure in the pharmaceutical, biotech, and CRO industries. With over a decade of global project management experience, she excels in leading cross-functional teams and managing the intricate balance between operational demands and financial constraints to successfully execute programs from inception to completion. Her extensive knowledge spans all trial phases across various global markets, including APAC, Europe and North America. Lakshmi’s experience spans several therapeutic areas, including gene therapy, rare diseases, respiratory, chronic inflammation, immunology, oncology, dermatology, CVM, and endocrinology.